Vimarsana
Biggest News Aggregation in the World

Ronald Perrone News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ronald Perrone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ronald Perrone Today - Breaking & Trending Today

XORTX Announces New Clinical Advisory Board Member - Vimarsana News

XORTX Announces New Clinical Advisory Board Member

CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (

XORTX Announces New Clinical Advisory Board Member - XORTX Therapeutics (NASDAQ:XRTX) - Vimarsana News

XORTX Announces New Clinical Advisory Board Member - XORTX Therapeutics (NASDAQ:XRTX)

CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANUA WKN: A3UNZ)), a biopharmaceutical company focused on developing

Metformin Well Tolerated in Polycystic Kidney Disease - Vimarsana News

Metformin Well Tolerated in Polycystic Kidney Disease

email article Metformin was both safe and well tolerated in patients with autosomal dominant polycystic kidney disease (ADPKD), the phase II TAME PKD trial found. The parallel-group, randomized trial of 97 participants found no significant increase in gastrointestinal symptoms over 24 months, according to Ronald Perrone, MD, of Tufts Medical Center in Boston, and colleagues. As measured by the Gastrointestinal Symptoms Rating Scale (GSRS), patients on metformin also didn't see any gastrointestinal tolerability issues compared with those on placebo. "Lactic acidosis and hypoglycemia were...